Skip to main content

Table 6 Risk of anxiety disorder by cancer type

From: Bidirectional relationship between anxiety disorder and cancer: a longitudinal population-based cohort study

Variables

Total

Anxiety

N

Cases

PY

Incidence

CHR (95% CI)

AHR (95% CI)

Cancer type

      

 Colon cancer

4754

404

31338.01

1.29

1.34 (1.20–1.50)**

1.72 (1.54–1.93)**

 Lung cancer

2760

91

7486.20

1.22

1.13 (0.91–1.40)

1.49 (1.20–1.86)**

 Breast cancer

4359

547

37342.59

1.46

1.26 (1.14–1.38)**

1.52 (1.37–1.68)**

 Liver cancer

3909

187

13641.23

1.37

1.38 (1.18–1.61)**

1.88 (1.60–2.21)**

 Oral cancer

1791

120

10108.06

1.19

1.69 (1.39–2.07)**

2.04 (1.65–2.52)**

 Prostate cancer

1351

95

7707.67

1.23

1.45 (1.16–1.82)*

1.93 (1.62–2.46)**

 Thyroid cancer

1107

137

11055.85

1.24

1.89 (1.55–2.31)**

2.34 (1.84–2.97)**

 Skin cancer

452

42

3589.75

1.17

1.76 (1.23–2.51)*

1.92 (1.32–2.78)**

 Stomach cancer

1591

101

7789.31

1.30

1.44 (1.17–1.79)**

1.87 (1.50–2.33)**

 Gynecological cancer

2977

320

25083.23

1.28

0.98 (0.87–1.10)

1.21 (1.07–1.37)*

 Brain cancer

507

29

3276.08

0.89

1.27 (0.85–1.89)

1.66 (1.08–2.55)*

 Urological cancer

1887

137

12489.51

1.10

1.06 (0.88–1.27)

1.44 (1.19–1.74)**

 Leukemia

455

31

2292.10

1.35

2.07 (1.39–3.08)*

2.54 (1.63–3.96)**

 Bone cancer

106

10

717.35

1.39

1.63 (0.81–3.25)

2.00 (0.94–4.26)

 Nose cancer

1186

105

8488.55

1.24

2.12 (1.70–2.65)**

3.12 (2.41–4.03)**

  1. Incidence: incidence density (100 per person-years)
  2. *: p <.05, **: p <.001, CHR: crude hazard ratio, AHR: adjusted hazard ratio controlling for age, sex, income, region, urbanization level, and CCI score, CCI: Charlson comorbidity index, CI: confidence interval, PY: person-years